Saturday, March 15, 2025 | 07:53 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

BoB allots Rs 500 cr to Serum after RBI liquidity tap for healthcare firms

SBI, HDFC Bank among lenders gearing up to support companies involved in mitigating Covid-19 outbreak.

Health workers conduct COVID-19 testing of passengers arriving from Maharashtra at Patna Railway Station, as coronavirus cases surge across the country, in Patna (Photo: PTI)
Premium

Health workers conduct COVID-19 testing of passengers arriving from Maharashtra at Patna Railway Station, as coronavirus cases surge across the country, in Patna (Photo: PTI)

Manojit Saha Mumbai
Banks have changed gear to cater to healthcare after the Reserve Bank of India on Wednesday opened a Rs 50,000 crore liquidity tap exclusively for companies involved in providing vaccine, oxygen, ventilator etc as the country fights a ferocious second wave of Covid-19 pandemic.

At least one lender, Bank of Baroda (BoB), has sanctioned Rs 500 crore to Serum Institute of India (SII),– which is producing Covishield, the vaccine against coronavirus infection.

State Bank of India (SBI), the country’s largest lender, has sanctioned a credit line to Bharat Biotech, which produces the Covaxin inoculation, recently, a top bank official said,

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in